Detection of gene fusions using targeted next-generation …?

Detection of gene fusions using targeted next-generation …?

WebTruSight Oncology 500 is a next-generation sequencing (NGS) assay that enables in-house comprehensive genomic profiling of tumor samples. It supports identification of all relevant DNA and RNA variants implicated in various solid tumor types. In addition, it accurately measures key current immuno-oncology biomarkers: microsatellite instability ... WebMay 20, 2024 · The NGS device is a companion diagnostic (CDx) to detect neurotrophic receptor tyrosine kinase (NTRK) gene fusions, which help the formation and growth of cancers. ArcherDX said that its NGS technology … .84 hour to minutes WebPrimer design is the foundation of NGS-based panel performance. Our in-house experts leverage the flexibility of Anchored Multiplex PCR (AMP™) chemistry and purpose-built … WebDescription. Gene fusions caused by chromosomal rearrangements are common in pediatric leukemias. The RNA heme fusion panel is a customized assay designed to detect gene … 84 h road acton WebThe Archer® FusionPlex® Lung Kit is a targeted next-generation sequencing (NGS) assay to detect EGFR vIII and MET exon 14 skipping events along with prominent ALK, … WebDec 20, 2024 · Coralville, IA — (Dec. 20, 2024) — Integrated DNA Technologies, Inc. (IDT) today announced it closed on the purchase of Next Generation Sequencing (NGS) … 84 huxtable terrace baldivis WebDescription. Gene fusions caused by chromosomal rearrangements are common in pediatric leukemias. The RNA heme fusion panel is a customized assay designed to detect gene fusions in pediatric acute lymphoblastic and myeloid leukemias (ALL and AML) using anchored multiplex PCR and next generation sequencing (Archer ® Fusion Plex). …

Post Opinion